Researchers Discover New Mechanism for Rapid Liver Regeneration to Restore Damaged Livers

Getty Images for Unsplash+

Researchers at the National Cancer Research Centre in Spain (CNIO) have discovered a mechanism that is triggered just minutes after acute liver damage occurs—and it could lead to treatments for those with severe liver problems.

The avenues for future treatments of liver damage include a diet enriched with the amino acid glutamate.

“Glutamate supplementation can promote liver regeneration and benefit patients in recovery following hepatectomy or awaiting a transplant,” wrote the authors in a paper published in ‘Nature’.

The liver is a vital organ, crucial to digestion, metabolism, and the elimination of toxins. It has a unique ability to regenerate, which allows it to replace liver cells damaged by the very toxins that these cells eliminate.

However, the liver stops regenerating in cases of diseases that involve chronic liver damage–such as cirrhosis—and such diseases are becoming increasingly prevalent, associated with poor dietary habits or alcohol consumption. So activating liver regeneration is key to treating the disease.

Learning to activate liver regeneration is therefore a priority today, to benefit patients with liver damage and also those who’ve had part of their liver cut out to remove a tumor.

The research has discovered in animal models this previously unknown mechanism of liver regeneration. It is a process that is triggered very quickly, just a few minutes after acute liver damage occurs, with the amino acid glutamate playing a key role.

“Our results describe a fundamental and universal mechanism that allows the liver to regenerate after acute damage,” explained Nabil Djouder, head of the CNIO Growth Factors, Nutrients and Cancer Group and senior author of the study.

A “complex and ingenious” perspective on liver regeneration

Liver regeneration was known to occur through the proliferation of liver cells, known as hepatocytes. However, the molecular mechanisms involved were not fully understood. This current discovery is very novel, as it describes communication between two different organs, the liver and bone marrow, involving the immune system, according to a CINO news release.

The results show that liver and bone marrow are interconnected by glutamate. After acute liver damage, liver cells, called hepatocytes, produce glutamate and send it into the bloodstream; through the blood, glutamate reaches the bone marrow, inside the bones, where it activates monocytes, a type of immune system cell. Monocytes then travel to the liver and along the way become macrophages – also immune cells. The presence of glutamate reprograms the metabolism of macrophages, and these consequently begin to secrete a growth factor that leads to an increase in hepatocyte production.

In other words, a rapid chain of events allows glutamate to trigger liver regeneration in just minutes, through changes in the macrophage metabolism. It is, says Djouder, “a new, complex and ingenious perspective on how the liver stimulates its own regeneration.”

The research also clarifies a previously unanswered question: how the various areas of the liver are coordinated during regeneration. In the liver, there are different types of hepatocytes, organized in different areas; the hepatocytes in each area perform specific metabolic functions. The study reveals that hepatocytes producing a protein known as glutamine synthetase, which regulates glutamate levels, play a key role in regeneration.

According to the CNIO group, when glutamine synthetase is inhibited, there is more glutamate in circulation, which accelerates liver regeneration. This is what happens when the liver suffers acute damage: glutamine synthase activity decreases, blood glutamate increases, and from there, the connection with the bone marrow is established, reprogramming macrophages and stimulating hepatocyte proliferation.
Possible therapeutic applications

The experiments have been carried out in mice, but the results have been tested with bioinformatics tools, using databases of mouse and human hepatocytes.

According to Djouder, “dietary glutamate supplementation may simply be recommended in the future after liver extirpation, and also to reduce liver damage caused by cirrhosis.”

The first author of the paper, CNIO researcher María del Mar Rigual also wants future research to explore using glutamate supplements in humans who have undergone liver resection for tumor removal. Researchers Discover New Mechanism for Rapid Liver Regeneration to Restore Damaged Livers
Read More........

Newly Identified Neural Stem Cells Could Transform Parkinson's Treatment

Credit: Gerd Altmann/ Pixabay

The detection of peripheral neural stem cells could transform treatment of Parkinson's disease and spinal cord injuries.

A team of researchers from more than ten laboratories in Europe, Asia and North America examined newly identified cells in mice called peripheral neural stem cells. These cells share important molecular and functional characteristics with neural stem cells of the brain. Peripheral neural stem cells have the same cell morphology, self-renewal and differentiation capacity as neural stem cells of the brain. They express several specific markers and have genome-wide transcriptional and epigenetic profiles that are consistent with those of neural stem cells in the brain. Furthermore, many peripheral neural stem cells that migrate out of the neural tube can differentiate into mature neurons and, to a limited extent, glial cells during embryonic and postnatal development.

The discovery of the new cell type not only provides new insights into the development of the mammalian nervous system. Their existence also challenges a long-standing hypothesis in neuroscience and, because they can be grown in substantial numbers in the petri dish, opens up new possibilities for regenerative medicine. Furthermore, obtaining neural stem cells from the brain is not a favoured method. By contrast, obtaining neural stem cells from other organs or tissues appears to be a viable and practical approach. “This was the longest-running project in my career. Originally, we wanted to replicate experiments that were published more than 10 years ago, namely, to induce pluripotent stem cells through low pH. Like other laboratories, we were unable to reproduce this. But fortunately, our attempts were not in vain: We found previously unknown peripheral neural stem cells, challenging the long-held dogma that neural stem cells do not exist outside the central nervous system,” says Hans Schöler from the Max Planck Institute for Molecular Biomedicine and the senior author of the study.

Dong Han, the lead researcher of the study, who carried out most of the experiments in this work as a member of Schöler's laboratory, emphasised the possible implications of this result: “If these cells exist in humans and can be propagated indefinitely as they can in mice, they could have enormous therapeutic potential. This is particularly exciting because accessible peripheral neural stem cells could provide a new avenue for neural repair and regeneration, bypassing many of the challenges associated with sourcing stem cells from the central nervous system.”
Plasticity in the nervous system

The discovery of peripheral neural stem cells outside the central nervous system suggests a previously unrecognised level of cellular plasticity within the nervous system. In contrast to neural crest-derived stem cells, which have a limited self-renewal capacity, peripheral neural stem cells closely resemble brain-derived neural stem cells and show the ability to sustain neurogenesis over an extended period of time.

Hans Schöler emphasised the crucial role of interdisciplinary cooperation in making this discovery possible: “We involved many laboratories with different areas of expertise to ensure that this study is watertight. The combination of genetic lineage analysis, single-cell analysis and functional tests in vivo provides compelling evidence that these peripheral neural stem cells are a genuine and previously unrecognised component of the mammalian nervous system.”
Potential Impact on Medicine

The ability to harness peripheral neural stem cells could have far-reaching implications for the treatment of neurodegenerative diseases and nerve cell repair strategies. If such cells exist in humans, they could provide an easily accessible source of neural stem cells that could be used in the future to treat diseases such as Parkinson's disease, spinal cord injury and other neurodegenerative disorders. Future studies will aim to establish the existence of peripheral neural stem cells in humans and explore their full therapeutic potential. The results thus pave the way for further research into the role of these cells in human biology and their potential application in the treatment of neurodegenerative diseases and in regenerative therapies.

Reference: Han D, Xu W, Jeong HW, et al. Multipotent neural stem cells originating from neuroepithelium exist outside the mouse central nervous system. Nat Cell Biol. 2025. doi: 10.1038/s41556-025-01641-w

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.b Newly Identified Neural Stem Cells Could Transform Parkinson's Treatment | Technology Networks
Read More........